M. Farao

466 total citations
9 papers, 399 citations indexed

About

M. Farao is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, M. Farao has authored 9 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Toxicology. Recurrent topics in M. Farao's work include Cancer therapeutics and mechanisms (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). M. Farao is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). M. Farao collaborates with scholars based in Italy, United Kingdom and Czechia. M. Farao's co-authors include Maria Grandi, Antonino Suarato, Enrico Pesenti, Marina Ripamonti, F. Spreafico, Leonard W. Seymour, Karel Ulbrich, Isabella C. Hume, Stephen R. Wedge and J. Strohalm and has published in prestigious journals such as Journal of Controlled Release, British Journal of Cancer and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

M. Farao

9 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Farao Italy	7	236	166	128	72	72	9	399
Marina Ripamonti Italy	11	237 1.0×	92 0.6×	105 0.8×	104 1.4×	46 0.6×	18	467
P. Vasey United Kingdom	4	274 1.2×	359 2.2×	126 1.0×	111 1.5×	200 2.8×	7	649
Péter Lázár Hungary	7	185 0.8×	122 0.7×	146 1.1×	27 0.4×	55 0.8×	9	426
Akinori Nagamitsu Japan	6	208 0.9×	290 1.7×	83 0.6×	49 0.7×	174 2.4×	11	482
Mao Yin United States	11	120 0.5×	120 0.7×	154 1.2×	72 1.0×	47 0.7×	31	421
Mary Mehlig United States	7	299 1.3×	164 1.0×	102 0.8×	60 0.8×	99 1.4×	9	473
David R. Khan United States	8	239 1.0×	261 1.6×	93 0.7×	29 0.4×	164 2.3×	9	491
Tetsuo Morinaga Japan	7	148 0.6×	148 0.9×	90 0.7×	48 0.7×	90 1.3×	8	541
D. Deprez-De Campeneere Belgium	8	289 1.2×	119 0.7×	218 1.7×	84 1.2×	44 0.6×	9	609
Xing Q. Pan United States	11	293 1.2×	193 1.2×	60 0.5×	54 0.8×	87 1.2×	15	543

Countries citing papers authored by M. Farao

Since Specialization

Citations

This map shows the geographic impact of M. Farao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Farao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Farao more than expected).

Fields of papers citing papers by M. Farao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Farao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Farao. The network helps show where M. Farao may publish in the future.

Co-authorship network of co-authors of M. Farao

This figure shows the co-authorship network connecting the top 25 collaborators of M. Farao. A scholar is included among the top collaborators of M. Farao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Farao. M. Farao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Caiolfa, Valeria R., Moreno Zamai, Antonio Fiorino, et al.. (2000). Polymer-bound camptothecin: initial biodistribution and antitumour activity studies. Journal of Controlled Release. 65(1-2). 105–119. 135 indexed citations

2.

Bedeschi, Angelo, Franco Zarini, Walter Cabri, et al.. (1996). Synthesis and antitumor activity of a new class of water soluble camptothecin derivatives. Bioorganic & Medicinal Chemistry Letters. 6(6). 671–674. 8 indexed citations

3.

Sola, Francesco, M. Farao, Enrico Pesenti, et al.. (1995). Antitumor activity of FCE 26644 a new growth-factor complexing molecule. Cancer Chemotherapy and Pharmacology. 36(3). 217–222. 24 indexed citations

4.

Farao, M., et al.. (1995). Antitumor activity of FCE 26644 a new growth-factor complexing molecule. Cancer Chemotherapy and Pharmacology. 36(3). 217–222. 3 indexed citations

5.

Sola, Francesco, M. Farao, Marina Ciomei, et al.. (1995). FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.. PubMed. 15(5-6). 222–31. 16 indexed citations

6.

Sola, Francesco, et al.. (1993). Inhibition of lung and liver tumor colonies in mice pretreated with suramin.. PubMed. 13(3). 163–8. 7 indexed citations

7.

Duncan, Ruth, Leonard W. Seymour, Stephen R. Wedge, et al.. (1992). Preclinical evaluation of polymer-bound doxorubicin. Journal of Controlled Release. 19(1-3). 331–346. 158 indexed citations

8.

Ripamonti, Marina, Gabriella Pezzoni, Enrico Pesenti, et al.. (1992). In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells. British Journal of Cancer. 65(5). 703–707. 44 indexed citations

9.

Seymour, Leonard W., Karel Ulbrich, F. Spreafico, et al.. (1991). Preclinical evaluation of polymer-bound doxorubicin. European Journal of Cancer and Clinical Oncology. 27. S52–S52. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact